HOLMDEL, N.J., June 30 /PRNewswire/ -- Sparta Systems, Inc. (Sparta), the maker of TrackWise(R) and the market leader in enterprise quality and compliance management software, today announced that Genzyme, a world-leading biotechnology company, has selected Sparta Systems to enhance its quality management program.
Genzyme purchased TrackWise to handle Corrective and Preventive Actions (CAPA) as well as deviations and investigations. The TrackWise solution was chosen to replace an existing solution and legacy systems due to its ease of use, extensive reporting capabilities, user interface and industry standard acceptance.
According to Dave Dentino, director, quality and technical operations systems at Genzyme Corporation, "TrackWise has already proven itself through user acceptance and ease of configuration. We have already realized a benefit through the ease with which the system enabled global harmonization of our business processes."
"We are pleased that Genzyme selected Sparta to provide a single, consolidated tool for managing the core elements of their quality management operation," said James E. McGowan, president and CEO, Sparta Systems. "TrackWise has become the industry standard due to its flexibility through configuration, ease of integration and unmatched functionality and we look forward to a future global deployment with Genzyme to all their manufacturing sites."
About Sparta Systems
Sparta Systems, Inc. is the industry leader for global quality and
compliance management systems. Its TrackWise product is a Web-based
enterprise software application used by quality, manufacturing, regulatory
affairs and business professionals to manage quality, compliance issues and
action items across the enterprise. The company has more than 14 years of
experience and an extensive customer base in life sciences and other highly
regulated industries. Sparta Systems offers its customers a complete
solution for global quality manag
|SOURCE Sparta Systems, Inc.|
Copyright©2008 PR Newswire.
All rights reserved